Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 257 Carcinoma, Intraductal, Noninfiltrating 24 Breast Carcinoma In Situ 21 Neoplasms 12 Neoplasm Metastasis 12 Breast Neoplasms, Male 12 Ovarian Neoplasms 10 Inflammatory Breast Neoplasms 7 Glioblastoma 6 Prostatic Neoplasms 5 Endometrial Neoplasms 5 Central Nervous System Neoplasms 5 Gliosarcoma 4 Fallopian Tube Neoplasms 4 Breast Cancer Female 4 Brain Neoplasms 4 Glioma 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Breast Diseases 3 Astrocytoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Medulloblastoma 2 Liver Neoplasms 2 Infertility 2

Interventions

trametinib 1 talimogene laherparepvec 1 spartalizumab 1 pembrolizumab 1 nazartinib 1 exemestane 1 canakinumab 1 Telomerase 1 Tamoxifen 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sentinel Lymph Node Biopsy 1 Pemetrexed 1 Paclitaxel 1 Mastectomy, Subcutaneous 1 Mastectomy, Segmental 1 Mammaplasty 1 Letrozole 1 Indocyanine Green 1 Doxorubicin 1 Docetaxel 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Ductal × Tamoxifen × Clear all

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Breast Neoplasms, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡